Eddour DC - Search Results

Year	Number of Results
2002	1
2004	1
2005	1
2006	1
2008	1
2010	1
2012	1
2013	1
2016	1
2023	1
2024	1
2025	0

1

Tacrolimus Pharmacokinetics is Associated with Gut Microbiota Diversity in Kidney Transplant Patients: Results from a Pilot Cross-Sectional Study.

Degraeve AL, Bindels LB, Haufroid V, Moudio S, Boland L, Delongie KA, Dewulf JP, Eddour DC, Mourad M, Elens L. Degraeve AL, et al. Among authors: eddour dc. Clin Pharmacol Ther. 2024 Jan;115(1):104-115. doi: 10.1002/cpt.3077. Epub 2023 Oct 30. Clin Pharmacol Ther. 2024. PMID: 37846607

2

Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.

Mourad M, Wallemacq P, De Meyer M, Malaise J, De Pauw L, Eddour DC, Goffin E, Lerut J, Haufroid V. Mourad M, et al. Among authors: eddour dc. Transplantation. 2008 Apr 15;85(7 Suppl):S19-24. doi: 10.1097/TP.0b013e318169c380. Transplantation. 2008. PMID: 18401258 Review.

3

Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?

Mourad M, Wallemacq P, König J, de Frahan EH, Eddour DC, De Meyer M, Malaise J, Squifflet JP. Mourad M, et al. Among authors: eddour dc. Clin Pharmacokinet. 2002;41(5):319-27. doi: 10.2165/00003088-200241050-00001. Clin Pharmacokinet. 2002. PMID: 12036390 Review.

4

Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot study.

De Meyer M, Haufroid V, Kanaan N, Darius T, Buemi A, De Pauw L, Eddour DC, Wallemacq P, Mourad M. De Meyer M, et al. Among authors: eddour dc. Pharmacogenomics. 2016 Jun;17(9):1019-27. doi: 10.2217/pgs-2016-0005. Epub 2016 Jun 8. Pharmacogenomics. 2016. PMID: 27266721

5

CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation.

Capron A, Mourad M, De Meyer M, De Pauw L, Eddour DC, Latinne D, Elens L, Haufroid V, Wallemacq P. Capron A, et al. Among authors: eddour dc. Pharmacogenomics. 2010 May;11(5):703-14. doi: 10.2217/pgs.10.43. Pharmacogenomics. 2010. PMID: 20415563

6

Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines.

Elens L, Capron A, van Schaik RH, De Meyer M, De Pauw L, Eddour DC, Latinne D, Wallemacq P, Mourad M, Haufroid V. Elens L, et al. Among authors: eddour dc. Ther Drug Monit. 2013 Oct;35(5):608-16. doi: 10.1097/FTD.0b013e318296045b. Ther Drug Monit. 2013. PMID: 24052064

7

CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study.

Haufroid V, Wallemacq P, VanKerckhove V, Elens L, De Meyer M, Eddour DC, Malaise J, Lison D, Mourad M. Haufroid V, et al. Among authors: eddour dc. Am J Transplant. 2006 Nov;6(11):2706-13. doi: 10.1111/j.1600-6143.2006.01518.x. Am J Transplant. 2006. PMID: 17049058 Free article.

8

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.

Haufroid V, Mourad M, Van Kerckhove V, Wawrzyniak J, De Meyer M, Eddour DC, Malaise J, Lison D, Squifflet JP, Wallemacq P. Haufroid V, et al. Among authors: eddour dc. Pharmacogenetics. 2004 Mar;14(3):147-54. doi: 10.1097/00008571-200403000-00002. Pharmacogenetics. 2004. PMID: 15167702

9

Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids.

Mourad M, Mourad G, Wallemacq P, Garrigue V, Van Bellingen C, Van Kerckhove V, De Meyer M, Malaise J, Eddour DC, Lison D, Squifflet JP, Haufroid V. Mourad M, et al. Among authors: eddour dc. Transplantation. 2005 Oct 15;80(7):977-84. doi: 10.1097/01.tp.0000174131.47469.d2. Transplantation. 2005. PMID: 16249748 Clinical Trial.

10

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil-Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J; TUMORAPA Study Group. Euvrard S, et al. N Engl J Med. 2012 Jul 26;367(4):329-39. doi: 10.1056/NEJMoa1204166. N Engl J Med. 2012. PMID: 22830463 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year